全球人副流感病毒季节性的区域与型别差异及气候因素影响:系统综述与meta分析
该研究系统检索2000年1月1日至2024年12月31日文献并整合监测数据,纳入64国141个站点306 719例人副流感病毒(hPIV)病例,分析型别与区域季节性差异及气候因素。发现hPIV-3季节性模式与其他三型不同,温带地区hPIV-1、hPIV-2、hPIV-4活动与气温下降和相对湿度升高相关,hPIV-3活动与气温升高相关;热带和亚热带气候模型表现欠佳。
要点
- hPIV-3在温带地区中位起始月北温带为4月(IQR 4–5月)、南温带为7月(7–7月),季节性在热带和亚热带仍较一致。
- hPIV-1、hPIV-2、hPIV-4在温带中位起始月北温带为8–10月、南温带为4–5月,热带和亚热带起始与高峰时间一致性较差。
- 温带地区hPIV-1、hPIV-2、hPIV-4活动与气温下降和相对湿度升高相关(均p<0.0001),hPIV-3活动与气温升高相关(rs=0.61;p<0.0001)。
核心结论
- 研究刻画了hPIV季节性的型别间与区域间差异,以及月度温度变异和相对湿度对不同hPIV型别全球季节性的不同影响。
- 研究认为这些发现对全球hPIV监测和不同地点流行预测有重要意义。
- 许多国家hPIV型别特异性季节性数据仍存在较大缺口,研究强调需扩大监测以改善hPIV流行特征描述和预测。
研究设计与样本
- 系统综述与meta分析,检索Embase、MEDLINE和Ovid Global Health 2000年1月1日至2024年12月31日发表的文献。
- 纳入研究需在整个研究期间连续检测hPIV并按月报告明确地理位置的季节性活动,排除少于20例、聚焦特定疾病或数据重复的文献。
- 共纳入115条记录(103项发表研究、5项合作者贡献研究、7个公共监测数据集),来自64个国家141个站点,合计306 719例病例。
- 采用年平均百分比法评估相对流行强度、流行起始与高峰月份及流行持续时间,以k-means法识别型别特异性传播区,并用局部回归模型探索气候因素。
- 研究注册于PROSPERO,注册号CRD42023370261。
主要发现
- hPIV-3与其他三型相比呈现独特的季节性模式:温带地区hPIV-3流行季通常出现在春季、夏季和冬季,北温带中位起始月为4月(IQR 4–5月),南温带为7月(7–7月)。
- hPIV-1、hPIV-2、hPIV-4流行季通常出现在秋季、冬季和夏季,北温带中位起始月为8月至10月,南温带为4月至5月。
- hPIV-1、hPIV-2、hPIV-4的流行起始和高峰时间在热带和亚热带地区较温带地区一致性更差,而hPIV-3的季节性在各区域总体保持一致。
- 北半球温带和亚热带国家在hPIV-1、hPIV-2、hPIV-3上通常聚为共享传播区(少数例外),南半球国家类似;北半球hPIV-1和hPIV-4高峰时间随纬度增加而延迟(hPIV-1 Pearson r=0.62,p=0.0012;hPIV-4 r=0.53,p=0.049)。
- 温带地区hPIV-1、hPIV-2、hPIV-4活动升高与气温下降和相对湿度升高相关(均p<0.0001),hPIV-3活动升高与气温升高相关(rs=0.61;p<0.0001);亚热带和热带地区气候模型表现欠佳。
关键数值与推荐
- 型别特异性气候模型拟合优于合并hPIV模型,表现为受试者工作特征曲线下面积值更大。
- 探索性分析显示六个纳入国家在解除COVID-19非药物干预后hPIV流行出现不同的时间偏移。
临床怎么用
- 原文未据此给出推荐。
- 研究认为结果对全球hPIV监测和不同地点流行预测的制定有重要意义。
- 研究强调许多国家hPIV型别特异性季节性数据仍存在较大缺口,需扩大监测以改善hPIV流行特征描述和预测。
局限性
- 许多国家hPIV型别特异性季节性数据仍存在较大缺口。
- 亚热带和热带地区气候模型表现欠佳。
- hPIV-1、hPIV-2、hPIV-4的流行起始和高峰时间在热带和亚热带地区较温带地区一致性更差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human parainfluenza viruses (hPIVs) are common viral causes of acute respiratory infections, resulting in substantial global disease burden. Seasonal patterns of hPIV epidemics can vary by geographical region and viral type, although these patterns are not well understood at a global level. We aimed to characterise regional and type-specific variations in hPIV seasonality and assess the potential role of climatic factors in explaining these variations. METHODS: In this systematic review and meta-analysis, we collected monthly aggregated seasonal activity data for hPIV and its four types (hPIV-1, hPIV-2, hPIV-3, and hPIV-4) from various sources, including a systematic search of Embase, MEDLINE, and Ovid Global Health, for literature published between Jan 1, 2000, and Dec 31, 2024; unpublished data contributed by an established collaborative network; and public viral surveillance datasets from online platforms. We included studies that continuously tested hPIVs throughout their study period and reported seasonal activity in defined geographical locations on a monthly basis (or if monthly data could be derived from reports). We excluded published studies if they had fewer than 20 cases, focused on specific medical conditions, or contained duplicate data from published literature or publicly available datasets. A prespecified collection template was used to collect data from members in the collaborative network. We extracted site-specific monthly case counts of combined hPIVs and each viral type and used the annual average percentage approach to assess relative circulating strength, epidemic onset and peak month, and epidemic duration by virus type and latitude. We identified type-specific transmission zones of countries with similar circulating patterns with the k-means method. A local regression model (selected by leave-one-out cross-validation) was used to explore climatic factors associated with variations in hPIV monthly circulating activity. The study was registered with PROSPERO, CRD42023370261. FINDINGS: We included 115 records in total: 103 studies identified from the published literature, five studies contributed by collaborators, and data from seven public surveillance datasets. We included 306 719 cases from 141 sites in 64 countries. We found that hPIV-3 exhibited distinctive seasonal patterns compared with the other three hPIV types. In temperate regions, hPIV-3 seasons typically occurred in spring, summer, and winter, with a median onset in April (IQR April-May) in the northern temperate region and July (July-July) in the southern temperate region. hPIV-1, hPIV-2, and hPIV-4 seasons typically occurred in autumn, winter, and summer, with median onsets between August and October in the northern temperate region and between April and May in the southern temperate region. Both epidemic onset and peak timing for hPIV-1, hPIV-2, and hPIV-4 were less consistent in tropical and subtropical regions than in temperate regions, whereas the seasonality of hPIV-3 remained generally consistent across regions. Northern temperate and subtropical countries typically clustered in shared transmission zones for hPIV-1, hPIV-2, and hPIV-3 with a few exceptions, as did countries in the southern hemisphere. Nevertheless, hPIV-1 and hPIV-4 peak timings were delayed as latitude increased in the northern hemisphere (Pearson's r=0·62 [p=0·0012] for hPIV-1 and r=0·53 [p=0·049] for hPIV-4). Type-specific climate models yielded better fits (with greater area under the receiver operating characteristic curve values) than models for combined hPIVs. In temperate regions, higher hPIV-1, hPIV-2, and hPIV-4 activity correlated with declining temperature and increasing relative humidity (all p values <0·0001), whereas higher hPIV-3 activity was correlated with rising temperature (rs=0·61; p<0·0001). In subtropical and tropical regions, the climate models showed suboptimal performance. Exploratory analyses showed differential timing shifts in hPIV epidemics across six included countries following the lifting of COVID-19 non-pharmacological interventions. INTERPRETATION: Our results characterise both between-type and regional variations in hPIV seasonality and the differential effects of monthly temperature variability and relative humidity on the global seasonality of different hPIV types. These findings have important implications for development of global hPIV surveillance and epidemic prediction in diverse locations. Substantial gaps in hPIV type-specific seasonality data remain in many countries, highlighting the need to expand surveillance to improve characterisation and prediction of hPIV epidemics. FUNDING: National Natural Science Foundation of China.
引用
- Chen J, Deng S, Xu X, et al. Regional and type-specific variations in the global seasonality of human parainfluenza viruses and the influence of climatic factors: a systematic review and meta-analysis. Lancet Glob Health. 2025. PMID: 40712614. doi:10.1016/S2214-109X(25)00188-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。